Statements (62)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Cell
|
gptkbp:amended_by |
Microenvironment
|
gptkbp:can_arise_from |
Normal cells
|
gptkbp:can_be_used_to |
Alternative energy sources
|
gptkbp:can_cause |
Tumors
|
gptkbp:can_create |
Tumor markers
|
gptkbp:can_detect |
Biopsy
|
gptkbp:can_develop_resistance_to |
Treatment
|
gptkbp:can_evade |
Apoptosis
|
gptkbp:can_exhibit_resistance_to |
Apoptotic signals
|
gptkbp:can_metastasize_to |
gptkb:Yes
|
gptkbp:can_secrete |
Exosomes
|
gptkbp:characteristic |
Uncontrolled growth
|
gptkbp:defeated |
Surrounding tissues
|
gptkbp:exhibits |
Heterogeneity
Epithelial-mesenchymal transition Drug resistance mechanisms Invasion properties Stem cell-like properties |
https://www.w3.org/2000/01/rdf-schema#label |
Cancer Cell
|
gptkbp:influence |
Systemic metabolism
|
gptkbp:initiated_by |
Tumor suppressor genes
|
gptkbp:interacts_with |
Immune cells
|
gptkbp:is_affected_by |
Environmental factors
Lifestyle factors Chemotherapy Radiation therapy Hormonal therapy |
gptkbp:is_analyzed_in |
Genomic sequencing
|
gptkbp:is_associated_with |
Genetic mutations
|
gptkbp:is_characterized_by |
Genomic instability
Altered signaling pathways Abnormal cell cycle regulation |
gptkbp:is_described_as |
gptkb:immortal
Aggressive Aneuploid Metabolically active Proliferative. |
gptkbp:is_influenced_by |
gptkb:Biology
|
gptkbp:is_monitored_by |
Imaging techniques
|
gptkbp:is_recognized_by |
Immunohistochemistry
Histological examination |
gptkbp:is_studied_in |
gptkb:Oncology
Clinical trials Cell culture Animal models |
gptkbp:is_targeted_at |
Monoclonal antibodies
Targeted therapy Small molecule inhibitors |
gptkbp:occurs_in |
Metabolic reprogramming
|
gptkbp:participated_in |
Angiogenesis
|
gptkbp:released |
Growth factors
|
gptkbp:scientific_classification |
gptkb:Malignant
Liquid tumor Solid tumor Type of cancer |
gptkbp:treatment |
gptkb:immunotherapy
gptkb:surgery Combination therapy |
gptkbp:bfsParent |
gptkb:Bert_Vogelstein
gptkb:Cell_Press |
gptkbp:bfsLayer |
5
|